P38 MAP kinases in the heart

Gene

Volumn 575, Issue 2, 2016, Pages 369-376

  Yokota, Tomohiro ^a   Wang, Yibin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart failure; Heart physiology; P38 MAP kinase; Stress signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38;

APOPTOSIS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME STRUCTURE; HEART; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNOREGULATION; MOLECULAR BIOLOGY; MUSCLE CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; CARDIOMEGALY; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; HEART MUSCLE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOMEGALY; CELL PROLIFERATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84942163556     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.09.030     Document Type: Review

References (96)

1. Aggeli I.K., Beis I., Gaitanaki C. Oxidative stress and calpain inhibition induce alpha B-crystallin phosphorylation via p38-MAPK and calcium signalling pathways in H9c2 cells. Cell. Signal. 2008, 20(7):1292-1302. 10.1016/j.cellsig.2008.02.019.
2. Allen M., Svensson L., Roach M., Hambor J., McNeish J., Gabel C.A. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 2000, 191(5):859-870.
3. Aouadi M., Binetruy B., Caron L., Le Marchand-Brustel Y., Bost F. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 2006, 88(9):1091-1098. 10.1016/j.biochi.2006.06.003.
4. Beardmore V.A., Hinton H.J., Eftychi C., Apostolaki M., Armaka M., Darragh J., Arthur J.S. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 2005, 25(23):10454-10464. 10.1128/MCB.25.23.10454-10464.2005.
5. Ben-Levy R., Hooper S., Wilson R., Paterson H.F., Marshall C.J. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr. Biol. 1998, 8(19):1049-1057.
6. Bhoumik A., Lopez-Bergami P., Ronai Z. ATF2 on the double-activating transcription factor and DNA damage response protein. Pigment Cell Res. 2007, 20(6):498-506. 10.1111/j.1600-0749.2007.00414.x.
7. Brault J.J., Pizzimenti N.M., Dentel J.N., Wiseman R.W. Selective inhibition of ATPase activity during contraction alters the activation of p38 MAP kinase isoforms in skeletal muscle. J. Cell. Biochem. 2013, 114(6):1445-1455. 10.1002/jcb.24486.
8. Braz J.C., Bueno O.F., Liang Q., Wilkins B.J., Dai Y.S., Parsons S., Molkentin J.D. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Invest. 2003, 111(10):1475-1486. 10.1172/JCI17295.
9. Breitwieser W., Lyons S., Flenniken A.M., Ashton G., Bruder G., Willington M., Jones N. Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev. 2007, 21(16):2069-2082. 10.1101/gad.430207.
10. Cargnello M., Roux P.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 2011, 75(1):50-83. 10.1128/MMBR.00031-10.
11. Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010, 429(3):403-417. 10.1042/BJ20100323.
12. Del Reino P., Alsina-Beauchamp D., Escos A., Cerezo-Guisado M.I., Risco A., Aparicio N., Cuenda A. Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38gamma and p38delta, linking inflammation and cancer in colitis-associated colon cancer. Cancer Res. 2014, 74(21):6150-6160. 10.1158/0008-5472.CAN-14-0870.
13. Drobic B., Perez-Cadahia B., Yu J., Kung S.K., Davie J.R. Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res. 2010, 38(10):3196-3208. 10.1093/nar/gkq030.
14. Eiras S., Fernandez P., Pineiro R., Iglesias M.J., Gonzalez-Juanatey J.R., Lago F. Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis. Cardiovasc. Res. 2006, 71(1):118-128. 10.1016/j.cardiores.2006.03.014.
15. Engel F.B., Hsieh P.C., Lee R.T., Keating M.T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(42):15546-15551. 10.1073/pnas.0607382103.
16. Engel F.B., Schebesta M., Duong M.T., Lu G., Ren S., Madwed J.B., Keating M.T. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005, 19(10):1175-1187. 10.1101/gad.1306705.
17. Engel F.B., Schebesta M., Keating M.T. Anillin localization defect in cardiomyocyte binucleation. J. Mol. Cell. Cardiol. 2006, 41(4):601-612. 10.1016/j.yjmcc.2006.06.012.
18. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001, 50(10):2363-2375.
19. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994, 78(6):1039-1049.
20. Gaestel M. MAPKAP kinases - MKs - two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 2006, 7(2):120-130. 10.1038/nrm1834.
21. Gallo K.A., Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 2002, 3(9):663-672. 10.1038/nrm906.
22. Ge B., Gram H., Di Padova F., Huang B., New L., Ulevitch R.J., Han J. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 2002, 295(5558):1291-1294. 10.1126/science.1067289.
23. Ghosh J., Das J., Manna P., Sil P.C. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol. 2009, 240(1):73-87. 10.1016/j.taap.2009.07.008.
24. Gong X., Ming X., Deng P., Jiang Y. Mechanisms regulating the nuclear translocation of p38 MAP kinase. J. Cell. Biochem. 2010, 110(6):1420-1429. 10.1002/jcb.22675.
25. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265(5173):808-811.
26. Han J., Lee J.D., Tobias P.S., Ulevitch R.J. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 1993, 268(33):25009-25014.
27. Hanada M., Kobayashi T., Ohnishi M., Ikeda S., Wang H., Katsura K., Tamura S. Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells. FEBS Lett. 1998, 437(3):172-176.
28. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298(5600):1911-1912. 10.1126/science.1072682.
29. Kaiser R.A., Bueno O.F., Lips D.J., Doevendans P.A., Jones F., Kimball T.F., Molkentin J.D. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J. Biol. Chem. 2004, 279(15):15524-15530. 10.1074/jbc.M313717200.
30. Kim J.K., Pedram A., Razandi M., Levin E.R. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J. Biol. Chem. 2006, 281(10):6760-6767. 10.1074/jbc.M511024200.
31. Kim S.J., Hwang S.G., Shin D.Y., Kang S.S., Chun J.S. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFkappa B-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 2002, 277(36):33501-33508. 10.1074/jbc.M202862200.
32. Koivisto E., Kaikkonen L., Tokola H., Pikkarainen S., Aro J., Pennanen H., Ruskoaho H. Distinct regulation of B-type natriuretic peptide transcription by p38 MAPK isoforms. Mol. Cell. Endocrinol. 2011, 338(1-2):18-27. 10.1016/j.mce.2011.02.015.
33. Kotlyarov A., Yannoni Y., Fritz S., Laass K., Telliez J.B., Pitman D., Gaestel M. Distinct cellular functions of MK2. Mol. Cell. Biol. 2002, 22(13):4827-4835.
34. Kukkonen-Macchi A., Sicora O., Kaczynska K., Oetken-Lindholm C., Pouwels J., Laine L., Kallio M.J. Loss of p38gamma MAPK induces pleiotropic mitotic defects and massive cell death. J. Cell Sci. 2011, 124(Pt 2):216-227. 10.1242/jcs.068254.
35. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81(2):807-869.
36. Li M., Liu J., Zhang C. Evolutionary history of the vertebrate mitogen activated protein kinases family. PLoS One 2011, 6(10). 10.1371/journal.pone.0026999.
37. Li Q., Zhang N., Zhang D., Wang Y., Lin T., Wang Y., Han J. Determinants that control the distinct subcellular localization of p38alpha-PRAK and p38beta-PRAK complexes. J. Biol. Chem. 2008, 283(16):11014-11023. 10.1074/jbc.M709682200.
38. Liang Q., Molkentin J.D. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 2003, 35(12):1385-1394.
39. Liao P., Georgakopoulos D., Kovacs A., Zheng M., Lerner D., Pu H., Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(21):12283-12288. 10.1073/pnas.211086598.
40. Liu D., He M., Yi B., Guo W.H., Que A.L., Zhang J.X. Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway. Int. J. Biochem. Cell Biol. 2009, 41(11):2315-2322. 10.1016/j.biocel.2009.05.021.
41. Liu H., Pedram A., Kim J.K. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38alpha-mediated activation of p53 and by down-regulating p53 inhibition on p38beta. Cardiovasc. Res. 2011, 89(1):119-128. 10.1093/cvr/cvq265.
42. Liu H., Yanamandala M., Lee T.C., Kim J.K. Mitochondrial p38beta and manganese superoxide dismutase interaction mediated by estrogen in cardiomyocytes. PLoS One 2014, 9(1). 10.1371/journal.pone.0085272.
43. Lu G., Kang Y.J., Han J., Herschman H.R., Stefani E., Wang Y. TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J. Biol. Chem. 2006, 281(9):6087-6095. 10.1074/jbc.M507610200.
44. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., Yue T.L. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999, 99(13):1685-1691.
45. Marber M.S., Rose B., Wang Y. The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J. Mol. Cell. Cardiol. 2011, 51(4):485-490. 10.1016/j.yjmcc.2010.10.021.
46. Mayr M., Hu Y., Hainaut H., Xu Q. Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J. 2002, 16(11):1423-1425. 10.1096/fj.02-0042fje.
47. Mitra A., Ray A., Datta R., Sengupta S., Sarkar S. Cardioprotective role of P38 MAPK during myocardial infarction via parallel activation of alpha-crystallin B and Nrf2. J. Cell. Physiol. 2014, 229(9):1272-1282. 10.1002/jcp.24565.
48. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., Shen M.M. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(19):10454-10459. 10.1073/pnas.180316397.
49. Nemoto S., Sheng Z., Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 1998, 18(6):3518-3526.
50. Nishida, K., Yamaguchi, O., Hirotani, S., Hikoso, S., Higuchi, Y., Watanabe, T., . . . Otsu, K. (2004). p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol., 24(24), 10611-10620. doi: . doi:10.1128/MCB.24.24.10611-10620.2004.
51. Ono, K., & Han, J. (2000). The p38 signal transduction pathway: activation and function. Cell. Signal., 12(1), 1-13.
52. Ota A., Zhang J., Ping P., Han J., Wang Y. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ. Res. 2010, 106(8):1404-1412. 10.1161/CIRCRESAHA.109.213769.
53. Pierrat B., Correia J.S., Mary J.L., Tomas-Zuber M., Lesslauer W. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J. Biol. Chem. 1998, 273(45):29661-29671.
54. Pillai V.B., Sundaresan N.R., Samant S.A., Wolfgeher D., Trivedi C.M., Gupta M.P. Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol. Cell. Biol. 2011, 31(11):2349-2363. 10.1128/MCB.01205-10.
55. Pulido R., Zuniga A., Ullrich A. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 1998, 17(24):7337-7350. 10.1093/emboj/17.24.7337.
56. Qi Y., Xu Z., Zhu Q., Thomas C., Kumar R., Feng H., Guo S. Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38alpha MAPK during insulin resistance. Diabetes 2013, 62(11):3887-3900. 10.2337/db13-0095.
57. Qian J., Ling S., Castillo A.C., Long B., Birnbaum Y., Ye Y. Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2012, 302(9):H1806-H1817. 10.1152/ajpheart.00929.2011.
58. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270(13):7420-7426.
59. Ren J., Zhang S., Kovacs A., Wang Y., Muslin A.J. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J. Mol. Cell. Cardiol. 2005, 38(4):617-623. 10.1016/j.yjmcc.2005.01.012.
60. Rolli M., Kotlyarov A., Sakamoto K.M., Gaestel M., Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J. Biol. Chem. 1999, 274(28):19559-19564.
61. Rose B.A., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 2010, 90(4):1507-1546. 10.1152/physrev.00054.2009.
62. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994, 78(6):1027-1037.
63. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68(2):320-344. 10.1128/MMBR.68.2.320-344.2004.
64. Sabio G., Arthur J.S., Kuma Y., Peggie M., Carr J., Murray-Tait V., Cuenda A. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 2005, 24(6):1134-1145. 10.1038/sj.emboj.7600578.
65. Salvador J.M., Mittelstadt P.R., Guszczynski T., Copeland T.D., Yamaguchi H., Appella E., Ashwell J.D. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat. Immunol. 2005, 6(4):390-395. 10.1038/ni1177.
66. Saxena M., Williams S., Brockdorff J., Gilman J., Mustelin T. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 1999, 274(17):11693-11700.
67. Saxena M., Williams S., Gilman J., Mustelin T. Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP). J. Biol. Chem. 1998, 273(25):15340-15344.
68. Schroder D., Heger J., Piper H.M., Euler G. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J. Mol. Med. (Berl) 2006, 84(11):975-983. 10.1007/s00109-006-0090-0.
69. Sharov V.G., Todor A., Suzuki G., Morita H., Tanhehco E.J., Sabbah H.N. Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur. J. Heart Fail. 2003, 5(2):121-129.
70. Stephanou A., Scarabelli T.M., Brar B.K., Nakanishi Y., Matsumura M., Knight R.A., Latchman D.S. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J. Biol. Chem. 2001, 276(30):28340-28347. 10.1074/jbc.M101177200.
71. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004, 23(6):1313-1324. 10.1038/sj.emboj.7600163.
72. Streicher J.M., Ren S., Herschman H., Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 2010, 106(8):1434-1443. 10.1161/CIRCRESAHA.109.213199.
73. Sudo T., Kawai K., Matsuzaki H., Osada H. p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem. Biophys. Res. Commun. 2005, 337(2):415-421. 10.1016/j.bbrc.2005.09.063.
74. Sumara G., Formentini I., Collins S., Sumara I., Windak R., Bodenmiller B., Ricci R. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 2009, 136(2):235-248. 10.1016/j.cell.2008.11.018.
75. Sundivakkam P.C., Natarajan V., Malik A.B., Tiruppathi C. Store-operated Ca2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38beta mitogen-activated protein kinase. J. Biol. Chem. 2013, 288(23):17030-17041. 10.1074/jbc.M112.411272.
76. Takekawa M., Maeda T., Saito H. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 1998, 17(16):4744-4752. 10.1093/emboj/17.16.4744.
77. Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000, 102(2):221-231.
78. Taniike M., Yamaguchi O., Tsujimoto I., Hikoso S., Takeda T., Nakai A., Otsu K. Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy. Circulation 2008, 117(4):545-552. 10.1161/CIRCULATIONAHA.107.710434.
79. Tanno M., Bassi R., Gorog D.A., Saurin A.T., Jiang J., Heads R.J., Marber M.S. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 2003, 93(3):254-261. 10.1161/01.RES.0000083490.43943.85.
80. Torcia M., De Chiara G., Nencioni L., Ammendola S., Labardi D., Lucibello M., Cozzolino F. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J. Biol. Chem. 2001, 276(42):39027-39036. 10.1074/jbc.M102970200.
81. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003, 22(6):1313-1324. 10.1093/emboj/cdg139.
82. Vlahopoulos S.A., Logotheti S., Mikas D., Giarika A., Gorgoulis V., Zoumpourlis V. The role of ATF-2 in oncogenesis. BioEssays 2008, 30(4):314-327. 10.1002/bies.20734.
83. Wang Y., Huang S., Sah V.P., Ross J., Brown J.H., Han J., Chien K.R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 1998, 273(4):2161-2168.
84. Watanabe K., Ma M., Hirabayashi K., Gurusamy N., Veeraveedu P.T., Prakash P., Aizawa Y. Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK. Am. J. Physiol. Heart Circ. Physiol. 2007, 292(3):H1269-H1277. 10.1152/ajpheart.00550.2006.
85. White A., Pargellis C.A., Studts J.M., Werneburg B.G., Farmer B.T. Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(15):6353-6358. 10.1073/pnas.0701679104.
86. Wierenga A.T., Vogelzang I., Eggen B.J., Vellenga E. Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp. Hematol. 2003, 31(5):398-405.
87. Wood, C. D., Thornton, T. M., Sabio, G., Davis, R. A., & Rincon, M. (2009). Nuclear localization of p38 MAPK in response to DNA damage. Int. J. Biol. Sci., 5(5), 428-437.
88. Xing B., Bachstetter A.D., Van Eldik L.J. Deficiency in p38beta MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse models. PLoS One 2013, 8(2). 10.1371/journal.pone.0056852.
89. Young P.R. Perspective on the discovery and scientific impact of p38 MAP kinase. J. Biomol. Screen. 2013, 18(10):1156-1163. 10.1177/1087057113497401.
90. Yu L., Yuan X., Wang D., Barakat B., Williams E.D., Hannigan G.E. Selective regulation of p38beta protein and signaling by integrin-linked kinase mediates bladder cancer cell migration. Oncogene 2014, 33(6):690-701. 10.1038/onc.2013.20.
91. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005, 15(1):11-18. 10.1038/sj.cr.7290257.
92. Zechner D., Thuerauf D.J., Hanford D.S., McDonough P.M., Glembotski C.C. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell Biol. 1997, 139(1):115-127.
93. Zhang J., Shen B., Lin A. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacol. Sci. 2007, 28(6):286-295. 10.1016/j.tips.2007.04.008.
94. Zhang S., Weinheimer C., Courtois M., Kovacs A., Zhang C.E., Cheng A.M., Muslin A.J. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 2003, 111(6):833-841. 10.1172/JCI16290.
95. Zhang Z., Shively J.E. Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes. PLoS One 2013, 8(7). 10.1371/journal.pone.0067649.
96. 2+-dependent manner. Int. J. Cardiol. 2010, 143(1):86-93. 10.1016/j.ijcard.2009.01.068.